ClinicalTrials.gov record
Completed Phase 3 Interventional

Secondary Prevention of Small Subcortical Strokes Trial

ClinicalTrials.gov ID: NCT00059306

Public ClinicalTrials.gov record NCT00059306. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 3:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Study identification

NCT ID
NCT00059306
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of British Columbia
Other
Enrollment
3,020 participants

Conditions and interventions

Interventions

  • Target of Blood Pressure Other
  • aspirin Drug
  • clopidogrel Drug
  • placebo Other

Other · Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2003
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
Apr 3, 2013

2003 – 2012

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
University of Southern Alabama Stroke Center Mobile Alabama 36617
Catholic Healthcare West Phoenix Arizona 85013
Mayo Clinic Scottsdale Scottsdale Arizona 85259
University of Arizona, Department of Neurology Tucson Arizona 85724
University of California San Diego Medical Center San Diego California 92103-8466
University of California San Francisco-Fresno San Francisco-Fresno California
Denver Englewood Colorado
Melbourne Melbourne Florida
Miami-University of Miami, Miller School of Medicine Miami Florida 33136
Emory University, Grady Health System Atlanta Georgia 30303
Mercy Medical Center-Ruan Neurology Clinical Research Des Moines Iowa 50314
University of Kentucky, Aging/Stroke Program Lexington Kentucky 40506-0230
Suburban Hospital Bethesda Maryland
Boston University Boston Massachusetts 02118
Wayne State Detroit Michigan 48201
Henry Ford Hospital, Department of Neurology Detroit Michigan 48202
Berman Center Minneapolis Minnesota 55404
Mayo Stroke Center KA-SL-13 Rochester Minnesota 55905
University of Washington Sant Louis Missouri
Tenet Health, St. Louis University St Louis Missouri 63110
St. John's Mercy St Louis Missouri 63141
Cooper University Hospital Camden New Jersey 08103
Buffalo Buffalo New York
Helen Hayes Hospital Haverstraw New York 10993
Columbia University Medical Center New York New York 10032
Rochester General Hospital Rochester New York 14621
University of Rochester Rochester New York 14642
Wake Forest University, Sciences-Neurology Winston-Salem North Carolina 27157-1078
Case Western Cleveland Ohio 44106
Metrohealth Medical Center Cleveland Ohio 44109
Ohio State University, Division of Stroke Columbus Ohio 43210
Oregon Health and Science University Portland Oregon 97239
Vanderbilt University Medical Center Nashville Tennessee 37232
University of Texas Southwestern Dallas Texas 75390-8897
Scurlock Stroke Center Houston Texas 77030
University of Texas Health Science Center San Antonio Texas 78229-3900
University of Washington Seattle Washington 98104-2499
Marshfield Clinic, Department of Neurology Marshfield Wisconsin 54449
Medical College of Wisconsin-Neurology Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00059306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2013 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00059306 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →